HTGM HTG Molecular Diagnostics, Inc. Stock Quote

HTGM [NASD]

Healthcare | Diagnostics & Research | USA

Index	-	P/E	-	EPS (ttm)	-2.48	Insider Own	0.40%	Shs Outstand	7.56M	Perf Week	-2.28%
Market Cap	5.09M	Forward P/E	-	EPS next Y	-0.83	Insider Trans	0.00%	Shs Float	6.48M	Perf Month	-37.39%
Income	-17.10M	PEG	-	EPS next Q	-0.71	Inst Own	23.80%	Short Float	1.63%	Perf Quarter	-71.10%
Sales	8.90M	P/S	0.57	EPS this Y	45.20%	Inst Trans	-29.28%	Short Ratio	0.18	Perf Half Y	-87.14%
Book/sh	1.38	P/B	0.49	EPS next Y	20.00%	ROA	-46.80%	Target Price	9.50	Perf Year	-81.16%
Cash/sh	2.91	P/C	0.23	EPS next 5Y	-	ROE	-107.30%	52W Range	0.55 - 6.98	Perf YTD	-87.52%
Dividend	-	P/FCF	-	EPS past 5Y	46.20%	ROI	-63.90%	52W High	-90.31%	Beta	2.07
Dividend %	-	Quick Ratio	2.50	Sales past 5Y	11.70%	Gross Margin	54.00%	52W Low	22.95%	ATR	0.11
Employees	87	Current Ratio	2.70	Sales Q/Q	11.50%	Oper. Margin	-	RSI (14)	31.08	Volatility	19.62% 13.41%
Optionable	No	Debt/Eq	1.42	EPS Q/Q	20.00%	Profit Margin	-	Rel Volume	0.23	Prev Close	0.63
Shortable	Yes	LT Debt/Eq	0.87	Earnings	May 12 AMC	Payout	-	Avg Volume	581.28K	Price	0.68
Recom	2.30	SMA20	-18.91%	SMA50	-47.26%	SMA200	-82.45%	Volume	133,176	Change	7.68%

May-11-20

Resumed

Cantor Fitzgerald

Overweight

Mar-26-20

Downgrade

Craig Hallum

Buy → Hold

May-16-17

Reiterated

Rodman & Renshaw

Buy

$4.50 → $6

Aug-22-16

Initiated

Rodman & Renshaw

Buy

Apr-04-16

Reiterated

Canaccord Genuity

Buy

$10 → $7

Nov-24-15

Reiterated

Canaccord Genuity

Buy

$12 → $10

Aug-24-15

Reiterated

Canaccord Genuity

Buy

$17 → $12

Jun-03-15

Initiated

JMP Securities

Mkt Outperform

Jun-02-15

Initiated

Leerink Partners

Outperform

$18

Jun-02-15

Initiated

Canaccord Genuity

Buy

$17

May-17-22 04:05PM	HTG Molecular Diagnostics to Participate in the H.C. Wainwright Global Investment Conference GlobeNewswire +7.68%
May-12-22 05:35PM	HTG Molecular Diagnostics, Inc. (HTGM) Reports Q1 Loss, Lags Revenue Estimates Zacks
04:01PM	HTG Molecular Diagnostics Reports First Quarter 2022 Results GlobeNewswire
May-05-22 08:00AM	HTG Molecular Diagnostics to Announce Q1 2022 Financial Results and Host Conference Call on Thursday, May 12 GlobeNewswire -8.07%
May-04-22 08:25AM	ConforMIS (CFMS) Reports Q1 Loss, Tops Revenue Estimates Zacks
Apr-13-22 08:00AM	HTG Expands Therapeutics Team GlobeNewswire +8.07%
Apr-06-22 04:05PM	HTG Expands Features of Proprietary HTG EdgeSeq Technology GlobeNewswire
Mar-31-22 04:50PM	HTG Releases Proof-of-Approach Whitepaper Establishing Utility of Transcriptome-Informed Approach to Drug Discovery GlobeNewswire -5.44%
Mar-29-22 04:05PM	HTG Molecular Diagnostics Reports Full Year 2021 Results GlobeNewswire
Mar-22-22 04:05PM	HTG Molecular Diagnostics to Announce Year End 2021 Financial Results and Host Conference Call on Tuesday, March 29 GlobeNewswire
Mar-18-22 08:00AM	HTG Molecular Diagnostics Announces $7.5 Million Private Placement GlobeNewswire -20.75%
Feb-03-22 04:05PM	HTG Names Renowned RNA Expert Dr. Robert Spitale to Therapeutics Scientific Advisory Board GlobeNewswire -8.73%
Jan-28-22 08:00AM	HTG Appoints Biopharmaceutical Industry Veteran Christopher Kiritsy to its Board of Directors GlobeNewswire
Jan-06-22 08:00AM	HTG Molecular Diagnostics Announces Certain Preliminary 2021 Unaudited Financial Results GlobeNewswire -12.63%
Jan-04-22 06:11AM	HTG Molecular Diagnostics (NASDAQ:HTGM) Has Debt But No Earnings; Should You Worry? Simply Wall St.
Dec-22-21 04:05PM	HTG Completes HTP Product Next-Phase Development Milestone GlobeNewswire
Dec-16-21 04:05PM	HTG Expands Therapeutics Scientific Advisory Board With Addition of Dr. Jerald Radich GlobeNewswire -8.74%
Dec-09-21 08:00AM	HTG Announces Major Sales Milestone for HTG Transcriptome Panel GlobeNewswire +20.94%
Nov-17-21 08:00AM	HTG and Icahn School of Medicine at Mount Sinai Announce Bladder Cancer Research Collaboration GlobeNewswire
Nov-15-21 08:00AM	HTG Molecular Diagnostics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
Nov-10-21 04:05PM	HTG Molecular Diagnostics Reports Third Quarter 2021 Results GlobeNewswire
Nov-02-21 04:05PM	HTG Molecular Diagnostics to Announce Third Quarter 2021 Financial Results and Host Conference Call on Wednesday, November 10 GlobeNewswire
Oct-06-21 09:33AM	The past three years for HTG Molecular Diagnostics (NASDAQ:HTGM) investors has not been profitable Simply Wall St.
Oct-05-21 08:00AM	HTG Expands Therapeutics Team GlobeNewswire
Sep-21-21 08:00AM	HTG Molecular Diagnostics to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference GlobeNewswire
Sep-08-21 04:10PM	HTG Molecular Diagnostics to Present at H.C. Wainwrights 23rd Annual Global Investment Conference GlobeNewswire
Aug-12-21 04:05PM	HTG Molecular Diagnostics Reports Second Quarter 2021 Results GlobeNewswire
Aug-05-21 08:00AM	HTGs New HTG Transcriptome Panel Launched with Commercial Availability in the U.S. and Europe GlobeNewswire
Aug-03-21 08:00AM	HTG Molecular Diagnostics to Announce Second Quarter 2021 Financial Results and Host Conference Call on Thursday, August 12 GlobeNewswire
Jul-23-21 08:00AM	HTG Molecular Diagnostics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
Jul-20-21 08:00AM	HTG Forms New Drug Discovery Business Unit GlobeNewswire
Jun-25-21 02:41AM	Is HTG Molecular Diagnostics (NASDAQ:HTGM) Using Debt In A Risky Way? Simply Wall St.
Jun-22-21 08:00AM	HTG Receives First Commercial Orders for its Planned HTG Transcriptome Panel and Announces the Signing of Two European Early Adopter Program Agreements GlobeNewswire +5.47%
Jun-21-21 05:29PM	Here is What Hedge Funds Think About HTG Molecular Diagnostics, Inc. (HTGM) Insider Monkey
Jun-14-21 08:00AM	HTG Completes Product Design Lock for its Planned Transcriptome Panel and Announces the Signing of the Three Early Adopter Program Collaboration Agreements GlobeNewswire +10.49%
May-24-21 04:11PM	HTG EdgeSeq Technology Highlighted in Several Posters Being Presented at the American Society of Clinical Oncology 2021 Virtual Conference GlobeNewswire
May-13-21 04:05PM	HTG Molecular Diagnostics Reports First Quarter 2021 Results and Provides a Corporate Update GlobeNewswire -5.10%
02:30PM	HTG Molecular Diagnostics, Inc. to Host Earnings Call ACCESSWIRE
May-04-21 04:01PM	HTG Molecular Diagnostics to Announce Q1 2021 Financial Results and Host Conference Call on Thursday, May 13 GlobeNewswire
Apr-06-21 09:20AM	HTG Molecular Drops Over 7% As 1Q Revenue Forecast Lags Estimates SmarterAnalyst
08:04AM	The Daily Biotech Pulse: Illumina Lights Up, Cara Soars On Index Inclusion, Novavax Starts Crossover Vaccine Study, Turning Point Data Readout Benzinga
Apr-05-21 04:03PM	HTG Molecular Diagnostics Reports Preliminary First Quarter 2021 Financial Results GlobeNewswire
Mar-25-21 04:01PM	HTG Molecular Diagnostics Reports Full Year 2020 Results GlobeNewswire
02:30PM	HTG Molecular Diagnostics, Inc. to Host Earnings Call ACCESSWIRE
Mar-18-21 12:30PM	Earnings Preview: HTG Molecular Diagnostics, Inc. (HTGM) Q4 Earnings Expected to Decline Zacks -5.82%
Mar-16-21 04:01PM	HTG Molecular Diagnostics to Announce Year End 2020 Financial Results and Host Conference Call on Thursday, March 25 GlobeNewswire
11:41AM	3 Cancer Diagnostic Stocks To Watch Following Roche's GenMark Buy Benzinga
Feb-26-21 08:00AM	HTG Concludes Feasibility Testing & Releases Second White Paper for its Planned Whole Transcriptome Panel Using HTG EdgeSeq Technology GlobeNewswire
Jan-19-21 04:10PM	HTG Announces Board of Directors Transition GlobeNewswire +11.87%
Jan-05-21 08:00AM	HTG Molecular Diagnostics Announces Certain Preliminary 2020 Unaudited Financial Results GlobeNewswire +22.24%
Dec-30-20 08:00AM	HTG Expands Patent Portfolio with New Canadian Patent for its Nuclease Protection Methods for Detection of Nucleotide Variants GlobeNewswire
Dec-18-20 08:00AM	HTG Announces First Collaborator in Early Access Program for its Prototype Whole Transcriptome Panel GlobeNewswire
Dec-08-20 04:01PM	HTG Announces an Early Access Program for its Prototype Whole Transcriptome Panel GlobeNewswire
Nov-29-20 02:23PM	Is HTG Molecular Diagnostics, Inc. (HTGM) A Good Stock To Buy? Insider Monkey
Nov-23-20 08:00AM	HTG Announces One-for-Fifteen Reverse Stock Split GlobeNewswire +10.21%
Nov-15-20 08:32AM	Newsflash: HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) Analysts Have Been Trimming Their Revenue Forecasts Simply Wall St.
Nov-10-20 04:29PM	HTG Molecular Diagnostics: Q3 Earnings Insights Benzinga
04:01PM	HTG Molecular Diagnostics Reports Third Quarter 2020 Results GlobeNewswire
02:45PM	HTG Molecular Diagnostics, Inc. to Host Earnings Call ACCESSWIRE
Nov-09-20 10:20AM	Earnings Preview for HTG Molecular Diagnostics Benzinga
Nov-02-20 04:01PM	HTG Demonstrates Technical Feasibility for a Whole Transcriptome Panel Using HTG EdgeSeq Technology GlobeNewswire
Oct-30-20 08:00AM	HTG Molecular Diagnostics to Announce Third Quarter 2020 Financial Results and Host Conference Call on Tuesday, November 10 GlobeNewswire
Oct-28-20 03:30PM	These 3 Penny Stocks Could Rack up Triple-Digit Gains, Says Leerink TipRanks +8.38%
Sep-08-20 04:01PM	HTG Molecular Diagnostics to Present Corporate Overview at Fall Investor Conferences GlobeNewswire
Aug-18-20 08:00AM	HTG Introduces Oncology Applications and Expands Analytics Capabilities with Release of New Software Update GlobeNewswire
Aug-14-20 02:17PM	HTG Molecular Provides Update on Patent Infringement Claims Against BioSpyder GlobeNewswire -12.36%
Aug-11-20 06:19PM	HTG Molecular Diagnostics: Q2 Earnings Insights Benzinga
05:25PM	HTG Molecular Diagnostics, Inc. (HTGM) Reports Q2 Loss, Tops Revenue Estimates Zacks
04:01PM	HTG Molecular Diagnostics Reports Second Quarter 2020 Results GlobeNewswire
Aug-10-20 04:01PM	HTG Molecular Diagnostics Announces New Commercialization and Distribution Agreement for Companion Diagnostics with QIAGEN GlobeNewswire
11:15AM	Earnings Preview: HTG Molecular Diagnostics Benzinga
Aug-05-20 04:01PM	HTG Molecular Diagnostics to Announce Second Quarter 2020 Financial Results and Host Conference Call on Tuesday, August 11 GlobeNewswire -5.30%
Aug-04-20 08:00AM	HTG Introduces HTG EdgeSeq Reveal RUO Oncology Applications GlobeNewswire +6.05%
Jul-30-20 04:01PM	HTG Expands RUO Profiling Menu with New NGS Platform Capability Assays GlobeNewswire +7.10%
Jul-28-20 04:05PM	HTG Launches New HTG EdgeSeq Pan B-Cell Lymphoma Panel GlobeNewswire
12:32PM	Will HTG Molecular Diagnostics, Inc. (HTGM) Report Negative Q2 Earnings? What You Should Know Zacks
Jul-23-20 04:05PM	HTG Announces Recipients of Its 2020 HTG EdgeSeq Autoimmune Panel Research Grants GlobeNewswire -5.24%
Jun-25-20 04:01PM	HTG Molecular Diagnostics Secures Senior Term Loan from Silicon Valley Bank GlobeNewswire -8.15%
Jun-24-20 08:56AM	Edited Transcript of HTGM earnings conference call or presentation 13-May-20 8:30pm GMT Thomson Reuters StreetEvents
Jun-23-20 04:01PM	HTG EdgeSeq Technology Highlighted in Multiple Posters Presented by Pharma Partners at the 2020 American Association for Cancer Research Virtual Meeting GlobeNewswire
Jun-18-20 04:01PM	HTG Introduces the HTG EdgeSeq Pan B-Cell Lymphoma Panel GlobeNewswire +6.68%
Jun-11-20 04:01PM	HTG Adds Three New Distributors in Europe, Expanding and Strengthening Reach in the Nordics and Eastern Europe GlobeNewswire -12.50%
Jun-04-20 10:13PM	Do Hedge Funds Love HTG Molecular Diagnostics, Inc. (HTGM)? Insider Monkey +11.97%
Jun-02-20 08:00AM	HTG EdgeSeq Technology Highlighted in Several Posters at ASCO GlobeNewswire
May-14-20 10:14AM	Top Ranked Momentum Stocks to Buy for May 14th Zacks +15.29%
May-13-20 05:25PM	HTG Molecular Diagnostics Inc (HTGM) Reports Q1 Loss, Misses Revenue Estimates Zacks -9.47%
04:05PM	HTG Molecular Diagnostics Reports First Quarter 2020 Results GlobeNewswire
May-11-20 04:01PM	HTG Molecular Diagnostics to Announce First Quarter 2020 Financial Results and Host Conference Call on Wednesday, May 13 GlobeNewswire
May-07-20 12:30PM	HTG Molecular Diagnostics Inc (HTGM) May Report Negative Earnings: Know the Trend Ahead of Q1 Release Zacks +7.13%
Mar-31-20 08:52AM	HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) Analysts Are Way More Bearish Than They Used To Be Simply Wall St.
Mar-27-20 09:38PM	Edited Transcript of HTGM earnings conference call or presentation 25-Mar-20 8:30pm GMT Thomson Reuters StreetEvents
Mar-25-20 04:01PM	HTG Molecular Diagnostics Reports Full Year 2019 Results GlobeNewswire
02:30PM	HTG Molecular Diagnostics, Inc. to Host Earnings Call ACCESSWIRE
Mar-18-20 12:30PM	Earnings Preview: HTG Molecular Diagnostics, Inc. (HTGM) Q4 Earnings Expected to Decline Zacks -6.71%
Mar-17-20 08:00AM	HTG Molecular Diagnostics to Announce Year End 2019 Financial Results and Host Conference Call on Wednesday, March 25 GlobeNewswire
Feb-27-20 12:30PM	Earnings Preview: HTG Molecular Diagnostics, Inc. (HTGM) Q4 Earnings Expected to Decline Zacks
Feb-19-20 08:00AM	HTG Molecular to Present Corporate Overview at the SVB Leerink 9th Annual Global Healthcare Conference GlobeNewswire
Feb-11-20 08:00AM	HTG EdgeSeq Mouse mRNA Tumor Response Panel Used by Researchers Targeting Cardiac Fibrosis with Engineered T-cells GlobeNewswire +5.21%
Feb-05-20 08:00AM	HTG EdgeSeq miRNA Whole Transcriptome Assay is Highly Reproducible in Biofluids for Potential Use as a Biomarker GlobeNewswire +6.05%
Jan-28-20 08:00AM	HTG Molecular Diagnostics Receives European Patent Grant Notification for Methods for Subtyping Diffuse Large B-cell Lymphoma GlobeNewswire

HTG Molecular Diagnostics, Inc. a commercial stage life sciences company, focuses on the precision medicine. The company offers instrumentation; consumables comprising assay kits; and software that automate sample processing and profiles various molecular targets. Its platforms generate a molecular profiling library for detection using next-generation sequencing. The company's marketed panels include HTG EdgeSeq precision immuno-oncology panel; HTG EdgeSeq miRNA whole-transcriptome assay; HTG EdgeSeq DLBCL cell of origin assay EU; HTG EdgeSeq DLBCL cell of origin assay; HTG lung fusions assay; HTG EdgeSeq ALKPlus assay EU; HTG immune response panel; and HTG mouse mRNA tumor response panel. It serves biopharmaceutical companies, academic research centers, and molecular testing laboratories. HTG Molecular Diagnostics, Inc. distributes its instruments and consumables directly in the United States and Europe; and through distributors in parts of Europe and internationally. The company has a governing agreement with QIAGEN Manchester Limited; and an agreement with Illumina, Inc. for the development of nuclease-protection-based RNA or DNA profiling tests. The company was formerly known as HTG, Inc. and changed its name to HTG Molecular Diagnostics, Inc. in March 2011. HTG Molecular Diagnostics, Inc. was incorporated in 1997 and is based in Tucson, Arizona.

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience